My husband has sever plaque psoriasis was put on Otelza on Friday, 4 days before PSA test and Lab, LDH 190 to 235, PSA 0.20 to 0.26
See History:
Diagnosed
By PSA Score 942.40 on 07/06/2022
Advance Metastatic Prostate Cancer with Ductal subtype
with focal cribform architecture in carcinoma (it is rare, unfortunately aggressive)
4 cores out of 15 with another questionable core with necrosis and questionable atypical cells
Stage 4 Gleason 8 3 Lytic Lesions (unusual or rare)
CT Scan, Pylarify Pet Scan, Bone Scan,
3T 3D guided MRI with write over
07/15/2022 Transperineal Biopsy
Started Firmagon 7/6/2022
Zytiga with Prednisone 7/20/2022
and Docetaxel Chemotherapy on 08/11/2022
Ductal Prostate Cancer is
aggressive, it cannot be monitored by psa score alone.
As it can still spread by low non existing psa numbers.
However, his Medical Oncologist states my husband does expresse a lot of PSA.
PSA 942.40 7/6/2022 Started treatment
To 2.87 08/03/2022
To 1.07 08/11/2022 Started Chemotherapy
To 0.41 09/01/2022
To 0.34 09/13/2022 Testosterone <7
To 0.24 10/18/2022 Testosterone <7
To 0.20 11/08/2022 Testosterone <7
Started Otelza 11/26/2022
Up To 0.26 11/29/2022 Testosterone <7
Concern about rise in PSA, also on chemotherapy and had his 5th session yesterday…
The lab work was prior to chemotherapy
So, could the PSA test be skewed by the new immune suppressant Oztela / Ampremilast for his psoriasis?